Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2004 by Munich Municipal Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Aventis Pharmaceuticals
Information provided by:
Munich Municipal Hospital
ClinicalTrials.gov Identifier:
NCT01035528
First received: December 17, 2009
Last updated: NA
Last verified: August 2004
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2010
  Estimated Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)